Atlas Trials

A Study in MPS VI to Assess Safety and Efficacy of Odiparcil

Clinical trial NCT03370653 · COMPLETED

Trial details

NCT number
NCT03370653
Sponsor
Inventiva Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis VI
Start date
2017-12-30
Primary completion
2019-09-24
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.